Hepatic Cytochrome P450 Regulation in Disease States

Authors: Cheng P-Y.; Morgan E.T.

Source: Current Drug Metabolism, Volume 2, Number 2, June 2001 , pp. 165-183(19)

Publisher: Bentham Science Publishers

Abstract:

Hepatic cytochrome P450 (P450) enzyme activities and gene expression can be profoundly altered in disease states. In general the levels of affected hepatic P450 enzymes are depressed by diseases, causing potential and documented impairment of drug clearance and clinical drug toxicity. However, modulation of P450s is enzyme selective and this selectivity differs among different diseases. This review will concentrate on regulation of P450s in diabetes, obesity and infectious and inflammatory disease, conditions that affect millions of people worldwide every day.

Keywords: Hepatic cytochrome P450; DIABETES AND OBESITY; CYP4A; CYP2E1; Hepatic P450s; LIVER DISEASES; INFLAMMATION AND INFECTION; Nitric Oxide; AhR-Regulated Genes; Peroxisome proliferator activated receptor; Aryl hydrocarbon receptor; Napthoflavone; Onstitutive androstane receptor; Interferon; Interleukin; Nitric oxide synthase; Tumor necrosis factor; Pregnane X receptor

Language: English

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1389200013338676

Publication date: 2001-06-01

• Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:
  
  In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Pharmacology
• By this author: Cheng P-Y. ;  Morgan E.T.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers